Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases successfully treated with CIP,% cases successfully treated with TET,% cases successfully treated with CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"11,908 (5,771, 19,944)","78.4% (62.7%, 98.1%)","0.0% (0.0%, 0.0%)","0.0% (0.0%, 0.0%)","78.4% (62.7%, 98.1%)","19.6 (15.7, 24.5)","0.0 (0.0, 0.0)","0.0 (0.0, 0.0)","19.6 (15.7, 24.5)",,,,,
"(p=0.750, q=0.975, c=0.500)","8,869 (5,707, 15,893)","88.2% (71.6%, 99.7%)","21.0% (13.9%, 26.2%)","3.2% (1.9%, 5.4%)","63.9% (50.9%, 76.2%)","22.0 (17.9, 24.9)","5.3 (3.5, 6.6)","0.8 (0.5, 1.3)","16.0 (12.7, 19.0)","-22.8% (-50.9%, 2.6%)","13.1% (0.8%, 30.0%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-18.1% (-28.2%, -8.3%)"
"(p=0.750, q=0.975, c=0.750)","8,906 (5,777, 15,688)","88.6% (71.4%, 99.8%)","31.0% (20.4%, 39.0%)","4.7% (2.7%, 8.0%)","52.8% (43.0%, 65.6%)","22.1 (17.9, 24.9)","7.7 (5.1, 9.8)","1.2 (0.7, 2.0)","13.2 (10.7, 16.4)","-22.2% (-51.1%, 3.2%)","13.6% (1.4%, 29.0%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-32.2% (-43.7%, -18.4%)"
"(p=0.750, q=0.975, c=1.000)","8,986 (5,900, 15,300)","89.0% (71.7%, 99.7%)","41.0% (26.8%, 51.6%)","6.2% (3.5%, 10.3%)","41.8% (30.1%, 57.6%)","22.3 (17.9, 24.9)","10.3 (6.7, 12.9)","1.5 (0.9, 2.6)","10.5 (7.5, 14.4)","-21.5% (-49.1%, 5.8%)","14.2% (1.5%, 28.6%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-46.3% (-61.0%, -28.1%)"
